200 related articles for article (PubMed ID: 38259291)
1. Neuroprotective effects and possible mechanisms of berberine in animal models of Alzheimer's disease: a systematic review and meta-analysis.
Dan L; Hao Y; Li J; Wang T; Zhao W; Wang H; Qiao L; Xie P
Front Pharmacol; 2023; 14():1287750. PubMed ID: 38259291
[No Abstract] [Full Text] [Related]
2. Neuroprotective Effect and Possible Mechanisms of Berberine in Diabetes-Related Cognitive Impairment: A Systematic Review and Meta-Analysis of Animal Studies.
Hao Y; Li J; Yue S; Wang S; Hu S; Li B
Front Pharmacol; 2022; 13():917375. PubMed ID: 35734409
[TBL] [Abstract][Full Text] [Related]
3. Effect of berberine on cognitive function and β-amyloid precursor protein in Alzheimer's disease models: a systematic review and meta-analysis.
Liu JY; Dai Y; He YX; Lin L
Front Pharmacol; 2023; 14():1301102. PubMed ID: 38293672
[No Abstract] [Full Text] [Related]
4. Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of β-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease.
Huang M; Jiang X; Liang Y; Liu Q; Chen S; Guo Y
Exp Gerontol; 2017 May; 91():25-33. PubMed ID: 28223223
[TBL] [Abstract][Full Text] [Related]
5. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.
Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M
Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971
[TBL] [Abstract][Full Text] [Related]
6. Effect of acupuncture on neuroinflammation in animal models of Alzheimer's disease: A preclinical systematic review and meta-analysis.
Wu ZG; Huang YJ; Wang TY; Deng CY; Xu ZR; Tang CZ
Front Aging Neurosci; 2023; 15():1110087. PubMed ID: 36936500
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effects of berberine in animal models of Alzheimer's disease: a systematic review of pre-clinical studies.
Yuan NN; Cai CZ; Wu MY; Su HX; Li M; Lu JH
BMC Complement Altern Med; 2019 May; 19(1):109. PubMed ID: 31122236
[TBL] [Abstract][Full Text] [Related]
8. Berberine ameliorates lipopolysaccharide-induced learning and memory deficit in the rat: insights into underlying molecular mechanisms.
Sadraie S; Kiasalari Z; Razavian M; Azimi S; Sedighnejad L; Afshin-Majd S; Baluchnejadmojarad T; Roghani M
Metab Brain Dis; 2019 Feb; 34(1):245-255. PubMed ID: 30456649
[TBL] [Abstract][Full Text] [Related]
9. The pharmacological activity of epigallocatechin-3-gallate (EGCG) on Alzheimer's disease animal model: A systematic review.
Zhang S; Zhu Q; Chen JY; OuYang D; Lu JH
Phytomedicine; 2020 Dec; 79():153316. PubMed ID: 32942205
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effect of berberine against environmental heavy metals-induced neurotoxicity and Alzheimer's-like disease in rats.
Hussien HM; Abd-Elmegied A; Ghareeb DA; Hafez HS; Ahmed HEA; El-Moneam NA
Food Chem Toxicol; 2018 Jan; 111():432-444. PubMed ID: 29170048
[TBL] [Abstract][Full Text] [Related]
11. Preclinical evidence and possible mechanisms of β-asarone for rats and mice with Alzheimer's disease: A systematic review and meta-analysis.
Du XY; Cao YS; Yang J; Guo LC; Zhang T; Yuan Q; Chen X; Hu LM
Front Pharmacol; 2022; 13():956746. PubMed ID: 36120381
[No Abstract] [Full Text] [Related]
12. Neuroprotective potential of berberine in modulating Alzheimer's disease via multiple signaling pathways.
Akbar M; Shabbir A; Rehman K; Akash MSH; Shah MA
J Food Biochem; 2021 Oct; 45(10):e13936. PubMed ID: 34523148
[TBL] [Abstract][Full Text] [Related]
13. Antioxidant and Anti-inflammatory Properties of Resveratrol in Diabetic Nephropathy: A Systematic Review and Meta-analysis of Animal Studies.
Hu HC; Lei YH; Zhang WH; Luo XQ
Front Pharmacol; 2022; 13():841818. PubMed ID: 35355720
[No Abstract] [Full Text] [Related]
14. Verum- versus Sham-Acupuncture on Alzheimer's Disease (AD) in Animal Models: A Preclinical Systematic Review and Meta-Analysis.
Zhao FY; Fu QQ; Zheng Z; Lao LX; Song HL; Shi Z
Biomed Res Int; 2020; 2020():5901573. PubMed ID: 32337259
[TBL] [Abstract][Full Text] [Related]
15. Berberine Reduces Aβ
Wu Y; Chen Q; Wen B; Wu N; He B; Chen J
Front Pharmacol; 2021; 12():640758. PubMed ID: 34349640
[TBL] [Abstract][Full Text] [Related]
16. Nano-Honokiol ameliorates the cognitive deficits in TgCRND8 mice of Alzheimer's disease via inhibiting neuropathology and modulating gut microbiota.
Qu C; Li QP; Su ZR; Ip SP; Yuan QJ; Xie YL; Xu QQ; Yang W; Huang YF; Xian YF; Lin ZX
J Adv Res; 2022 Jan; 35():231-243. PubMed ID: 35024199
[TBL] [Abstract][Full Text] [Related]
17. Investigating Neuroprotective Potential of Berberine, Levetiracetam and their Combination in the Management of Alzheimer's Disease Utilizing Drug Repurposing Strategy.
Singh A; Dhaneshwar S; Mazumder A
Curr Rev Clin Exp Pharmacol; 2023; 18(2):182-190. PubMed ID: 34515019
[TBL] [Abstract][Full Text] [Related]
18. [Galangin alleviates learning and memory impairments in APP/PS1 double- transgenic mice by regulating Akt/MEF2D/Beclin-1 signaling pathway].
Huang LP; Zhong XQ; Zhou XY; Deng MQ; Wu MJ; Deng MZ
Zhongguo Zhong Yao Za Zhi; 2022 May; 47(10):2729-2737. PubMed ID: 35718493
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of berberine in diabetic nephropathy: A systematic review and meta-analysis revealing the mechanism of action.
Hu S; Wang J; Liu E; Zhang X; Xiang J; Li W; Wei P; Zeng J; Zhang Y; Ma X
Pharmacol Res; 2022 Nov; 185():106481. PubMed ID: 36195307
[TBL] [Abstract][Full Text] [Related]
20. Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting β/γ-Secretases Activity and Enhancing α-Secretases.
Cai Z; Wang C; He W; Chen Y
Curr Alzheimer Res; 2018; 15(11):1045-1052. PubMed ID: 29962345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
